🏛️ Verified NIH Record • Updated 2026-08-25
BUprenorphine Versus Morphine for Postcesarean Analgesia (BUMP) (NCT07786012)
🟡 Not Yet Recruiting Phase4 💊 Investigational Drug / Biologic Sponsor: Icahn School of Medicine at Mount Sinai
🩺 Plain-English Summary (8th-Grade Level)
In this study the researchers are randomizing pregnant patients coming for elective cesarean delivery to receive either intrathecal buprenorphine or morphine for their analgesia.
Who can join: To join this study, participants generally need to meet the listed inclusion criteria (1 items) and avoid the listed exclusions (5 items).
Location: Mount Sinai Hospital — New York, New York
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistCheck every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).
Usually NOT eligible if any of the following apply:
- Exclusion Criteria:
- allergy to buprenorphine or morphine
- will not have neuraxial anesthesia
- chronic pain conditions
- opiate based medications
🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.
📍 All Participating Trial Locations (1 Sites)
- Mount Sinai Hospital — New York, New York
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.